BIOMAT Database Logo BIOMAT Database Logo

Hyperacute rejection of HLA-AB-identical renal allografts associated with B lymphocyte and endothelial reactive antibodies. 1982

A T Ahern, and S B Artruc, and P DellaPelle, and A B Cosimi, and P S Russell, and R B Colvin, and T C Fuller

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003601 Cytotoxicity Tests, Immunologic The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitized lymphocyte, an antibody, or complement. AHG-CDC Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Tests,Microcytotoxicity Tests,Anti Human Globulin Complement Dependent Cytotoxicity Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunologic,Cytotoxicity Tests, Anti-Human Globulin Complement-Dependent,Cytotoxicity Tests, Immunological,Immunologic Cytotoxicity Test,Immunologic Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin-Augmented,Lymphocytotoxicity Tests, Antiglobulin-Augmented,Microcytotoxicity Test,AHG CDC Tests,AHG-CDC Test,Anti Human Globulin Complement Dependent Cytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunological,Cytotoxicity Tests, Anti Human Globulin Complement Dependent,Immunological Cytotoxicity Test,Immunological Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin Augmented,Lymphocytotoxicity Tests, Antiglobulin Augmented
D004727 Endothelium A layer of epithelium that lines the heart, blood vessels (ENDOTHELIUM, VASCULAR), lymph vessels (ENDOTHELIUM, LYMPHATIC), and the serous cavities of the body. Endotheliums
D005260 Female Females
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).

Related Publications

A T Ahern, and S B Artruc, and P DellaPelle, and A B Cosimi, and P S Russell, and R B Colvin, and T C Fuller
Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells.
September 1966, Lancet (London, England),
A T Ahern, and S B Artruc, and P DellaPelle, and A B Cosimi, and P S Russell, and R B Colvin, and T C Fuller
Hyperacute and acute fulminating rejection of human renal allografts.
December 1972, Transplantation proceedings,
A T Ahern, and S B Artruc, and P DellaPelle, and A B Cosimi, and P S Russell, and R B Colvin, and T C Fuller
Putative antibody-mediated rejection with C4d deposition in HLA-identical, ABO-compatible renal allografts.
December 2006, Transplantation proceedings,
A T Ahern, and S B Artruc, and P DellaPelle, and A B Cosimi, and P S Russell, and R B Colvin, and T C Fuller
B-lymphocyte and kidney cell cross-reactive antibodies eluted from rejected human renal allografts.
December 1979, Transplantation proceedings,
A T Ahern, and S B Artruc, and P DellaPelle, and A B Cosimi, and P S Russell, and R B Colvin, and T C Fuller
B-lymphocyte-specific antibodies in human renal allografts.
March 1979, Transplantation proceedings,
A T Ahern, and S B Artruc, and P DellaPelle, and A B Cosimi, and P S Russell, and R B Colvin, and T C Fuller
[Prevention of hyperacute active rejection of renal allografts in primates using F(ab')2 and adequate immunosuppression].
September 1975, AMB : revista da Associacao Medica Brasileira,
A T Ahern, and S B Artruc, and P DellaPelle, and A B Cosimi, and P S Russell, and R B Colvin, and T C Fuller
Endothelial changes associated with hyperacute, acute, and chronic renal allograft rejection in man.
March 1973, Transplantation proceedings,
A T Ahern, and S B Artruc, and P DellaPelle, and A B Cosimi, and P S Russell, and R B Colvin, and T C Fuller
Antibodies to vascular endothelial cells in chronic rejection of renal allografts.
March 2000, Transplantation proceedings,
A T Ahern, and S B Artruc, and P DellaPelle, and A B Cosimi, and P S Russell, and R B Colvin, and T C Fuller
Prevention of hyperacute rejection by removal of antibodies to HLA immediately before renal transplantation.
November 1996, Lancet (London, England),
A T Ahern, and S B Artruc, and P DellaPelle, and A B Cosimi, and P S Russell, and R B Colvin, and T C Fuller
Non-HLA antibodies after rejection of HLA identical kidney transplants.
January 2006, Clinical transplants,
Copied contents to your clipboard!